Skip to main content

Table 1 Patient clinicopathological characteristics

From: Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer

Characteristic

N° patients

%

Total number of patients

273

 

Age (years)

  

   Mean

55.5

 

   SD

13.7

 

Menopausal status

  

   Premenopausal

111

41

   Postmenopausal

162

56

Tumor size

  

   T1

58

21

   T2

148

54

   T3

45

17

   T4

22

8

Lymph node status

  

   N0

118

43

   N1

83

30

   N2

72

27

Distant metastasis

  

   M0

256

94

   M1

17

6

Metastatic sites location

  

   Bone

7

 

   Liver

3

 

   Skin

2

 

   Brain

2

 

   Not documented

3

 

Clinical stage

  

   I

39

14

   II

137

50

   III

81

30

   IV

16

6

Tumor grade

  

   1

45

17

   2

134

50

   3

86

33

   Not documented

8

 

Hormone receptor status, crossed results

  

   ER+PR+a

140

52

   ER+PR-

50

18

   ER-PR+

4

2

   ER-PR-

75

28

   Not documented

4

 
  1. aER: estrogen receptor; PR: progesterone receptor